GSK Pharma Q1 FY25 results: Net profit rises 37%, revenue up 6.9%
GSK Pharma's stocks were up by 2.49 per cent, ending the day's trade at Rs 2,824.45 apiece on the Bombay Stock Exchange (BSE)